banner news

Singapore, February 21, 2020 – To date, the novel Coronavirus has killed more than 2,000 people with more than 75,000 confirmed cases worldwide.

 

Leveraging its real-time PCR point-of-care platform, the VitaPCRTM, which was introduced during the American Association of Clinical Chemistry Conference (AACC) in Anaheim last year, the test will deliver results in 20 minutes with a hands-on time of 1 minute. With minimal training required, the solution is ideal for the near-patient and point-of-care settings, allowing efficient and rapid triage of suspected cases of the COVID-19, even in areas with limited resources.

 

The advantages are:

 

- The 20 minutes sample to result allows rapid and efficient screening of novel Coronavirus resulting in immediate diagnosis for faster patient triage and quarantine procedures for infected individuals.

 

- The VitaPCRTM platform is versatile. It can be deployed without additional equipment in various clinical settings such as laboratory, ER, clinics, and even at the point-of-care or point-of-entry such as the airports and seaports.

 

- Combining speed and ease of use, it can immediately increase any facility testing output, reducing the over-reliance on a crowded centralized laboratory for testing as well as the risk of human errors.

 

- Requiring little to no training to operate; it reduces the amount of highly trained technicians required to prepare and perform the tests every day while increasing the laboratory testing capacity.

 

VitaPCRTM COVID-19 Assay will be available shortly while pending Emergency Use Authorization from the US FDA and Emergency Use Listing from the WHO. 

 

 

 


 

About Credo Diagnostics Biomedical Pte. Ltd.

Credo Diagnostics Biomedical develops and manufactures innovative, easy-to-use and rapid molecular diagnostic solutions for Point-of-Care (POC) applications at affordable costs without compromising accuracy and speed in the areas of Animal Health, Human Health, and Human Wellness. Leveraging solid and established science, combined with efficient integration and strategic innovation, Credo Diagnostics Biomedical provides advanced medical technologies for all.

 

CONTACT

We at Credo pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.